Nuclear medicine imaging of diabetic foot infection: results of meta-analysis

Nuclear Medicine Communications

Volumn 27, Issue 10, 2006, Pages 757-764

  Capriotti, Gabriela ^a   Chianelli, Marco ^b   Signore, Alberto ^a  

^a SAPIENZA UNIVERSITY OF ROME   (Italy)

^b REGINA APOSTOLORUM HOSPITAL   (Italy)

Author keywords

Diabetic foot; Nuclear medicine; Osteomyelitis; Radiopharmaceuticals

Indexed keywords

IMMUNOGLOBULIN F(AB) FRAGMENT; IMMUNOGLOBULIN G; LEUKOCYTE IN 111; MEDRONATE TECHNETIUM TC 99M; MONOCLONAL ANTIBODY TC 99M; RADIOPHARMACEUTICAL AGENT;

ARTICLE; CLINICAL FEATURE; CLINICAL TRIAL; DATA ANALYSIS; DIABETIC FOOT; DIABETIC PATIENT; DIAGNOSTIC IMAGING; DIAGNOSTIC PROCEDURE; DIAGNOSTIC VALUE; EVALUATION; HUMAN; LEUKOCYTE; MEDICAL LITERATURE; MEDICAL RECORD; META ANALYSIS; NUCLEAR MAGNETIC RESONANCE IMAGING; NUCLEAR MEDICINE; OSTEOMYELITIS; PRACTICE GUIDELINE; RADIATION MONITORING; RADIOGRAPHY; SCINTIGRAPHY; SYSTEMATIC REVIEW;

DECISION TREES; DIABETIC FOOT; DISEASE PROGRESSION; HUMANS; MAGNETIC RESONANCE IMAGING; NUCLEAR MEDICINE; OSTEOMYELITIS; RADIOLOGY; RADIOPHARMACEUTICALS;

EID: 33748755176     PISSN: 01433636     EISSN: 14735628     Source Type: Journal    
DOI: 10.1097/01.mnm.0000230065.85705.b3     Document Type: Article

References (83)

1. Lavery LA, Ashry HR, van Houtum W, Pugh JA, Harkless LB, Basu S. Variation in the incidence and proportion of diabetes-related amputations in minorities. Diabetes Care 1996; 19:48-52.
2. Armstrong DG, Lavery LA, Quebedeaux TL, Walker SC. Surgical morbidity and the risk of amputation due to infested puncture wounds in diabetic versus nondiabetic adults. South Med J 1997; 90:384-389.
3. Most RS, Sinnock KP. The epidemiology of lower extremity amputations in diabetic individuals. Diabetes Care 1983; 6:87-91.
4. Caballero E, Frykberg RG. Diabetic foot infection. J Foot Ankle Surg 1998; 37:248-255.
5. Slovenkai MP. Getting - and keeping - a leg up on diabetes related problems. J Musculoskel Med 1998; 15:46-54.
6. Ramsey SD, Newton K, Blough D, McCulloch DK, Sandhu N, Reiber GE, et al. Incidence, outcomes, and cost of foot ulcers in patients with diabetes. Diabetes Care 1999; 22:382-387.
7. Reiberg GE, Lipsky BA, Gibbons GW. The burden of diabetic foot ulcers. Am J Surg 1998; 176:5S-10S.
8. Laing P. The development and complications of diabetic foot ulcers. Am J Surg 1998; 176:11S-19S.
9. Sumpio BE. Foot ulcers. N Engl J Med 2000; 343:787-793.
10. Gierbolini R. Charcot's foot: often overlooked complication of diabetes. J Am Acad Phys Assist 1994; 12:62-68.
11. Wheat LJ, Allen SD, Henri M, Kernek CB, Siders JA, Kuebler T, et al. Diabetic foot infection: bacteriologic analysis. Arch Intern Med 1986; 146:1935-1940.
12. Palestro CJ, Torres MA. Radionuclide imaging in orthopedic infection. Semin Nucl Med 1997; 27:334-335.
13. Seabold JE, Flickinger FW, Kao SCS, Gleason TJ, Kahn D, Nepola JV, et al. Indium-111-leukocytes/technetium-99m-MDP bone and magnetic resonance imaging: difficulty of diagnosis of osteomyelitis in patients with neuropathic arthropathy. J Nucl Med 1990; 31:549-556.
14. Craig JG, Aimn MB, Wu K, Eyler WR, van Holsbeeck MT, Bouffard JA, et al. Osteomyelitis of the diabetic foot: MR imaging-pathologic correlation. Radiology 1997; 36:120-126.
15. Palestro CJ, Mehta HH, Patel M, Freeman SJ, Harrington WN, Tomas MB, et al. Marrow versus infection in the Charcot joint: indium-111 leukocytes and technetium-99m sulfur colloid scintigraphy. J Nucl Med 1998; 39:346-350.
16. Resnick D, Kang HS. Internal derangements of joints: emphasis on MR imaging. Philadelphia: Saunders; 1997.
17. Maugendre D, Poirier JY. Nuclear medicine in the diagnosis of diabetic foot osteomyelitis. Diabetes Metab 2001; 27:396-400.
18. Unal SN, Birinci H, Baktiroglu S, Cantez S. Comparison of Tc-99m methylene diphosphonate, Tc-99m human immune globulin, and Tc-99m-labeled white blood cell scintigraphy in the diabetic foot. Clin Nucl Med 2001; 26:1016-1021.
19. Morrison WB, Ledermann HP, Schweitzer ME. MR imaging of the diabetic foot. Magn Reson Imaging Clin N Am 2001; 9:603-613.
20. Love C, Tomas MB, Marwin SE, Pugliese PV, Palestro CJ. Role of nuclear medicine in diagnosis of the infected joint replacement. Radiographics 2001; 21:1229-1238.
21. Devillers A, Garin E, Polard JL, Poirier JY, Arvieux C, Girault S, et al. Comparison of Tc-99m-labelled antileukocyte fragment Fab′ and Tc-99m-HMPAO leukocyte scintigraphy in the diagnosis of bone and joint infections: a prospective study. Nucl Med Commun 2000; 21:747-753.
22. Devillers A, Moisan A, Hennion F, Garin E, Poirier JY, Bourguet P. Contribution of technetium-99m hexamethylpropylene amine oxime labelled leucocyte scintigraphy to the diagnosis of diabetic foot infection. Eur J Nucl Med 1998; 25:132-138.
23. Tomas MB, Patel M, Marwin SE, Palestro CJ. The diabetic foot. Br J Radiol 2000; 73:443-450.
24. Brash PD, Foster J, Vennart W, Anthony P, Tooke JE. Magnetic resonance imaging techniques demonstrate soft tissue damage in the diabetic foot. Diabet Med 1999; 16:55-61.
25. Harwood SJ, Valdivia S, Hung GL, Quenzer RW. Use of Sulesomab, a radiolabeled antibody fragment, to detect osteomyelitis in diabetic patients with foot ulcers by leukoscintigraphy. Clin Infect Dis 1999; 28:1200-1205.
26. Jay PR, Michelson JD, Mizel MS, Magid D, Le T. Efficacy of three-phase bone scans in evaluating diabetic foot ulcers. Foot Ankle Int 1999; 20:347-355.
27. Enderle MD, Coerper S, Schweizer HP, Kopp AE, Thelen MH, Meisner C, et al. Correlation of imaging techniques to histopathology in patients with diabetic foot syndrome and clinical suspicion of chronic osteomyelitis. The role of high-resolution ultrasound. Diabetes Care 1999; 22:294-299.
28. Becker W. Imaging osteomyelitis and the diabetic foot. Q J Nucl Med 1999; 43:9-20.
29. Harwood SJ, Camblin JG, Hakki S, Morrissey MA, Laven DL, Zangara LM, et al. Use of technetium antigranulocyte monoclonal antibody Fab′ fragments for the detection of osteomyelitis. Cell Biophys 1994; 24-25:99-107.
30. Vesco L, Boulahdour H, Hamissa S, Kretz S, Montazel JL, Perlemuter L, et al. The value of combined radionuclide and magnetic resonance imaging in the diagnosis and conservative management of minimal or localized osteomyelitis of the foot in diabetic patients. Metabolism 1999; 48:922-927.
31. Lipman BT, Collier BD, Carrera GF, Timins ME, Erickson SJ, Johnson JE, et al. Detection of osteomyelitis in the neuropathic foot: nuclear medicine, MRI and conventional radiography. Clin Nucl Med 1998; 23:77-82.
32. Remedios D, Valabhji J, Oelbaum R, Sharp P, Mitchell R. 99mTc-nanocolloid scintigraphy for assessing osteomyelitis in diabetic neuropathic feet. Clin Radiol 1998; 53:120-125.
33. Makler PT. Unusual combination of Tc-99m MDP and In-111 WBC scans in gangrene of the foot. Clin Nucl Med 1998; 23:35-39.
34. Palestro CJ, Torres MA. Radionuclide imaging in orthopedic infections. Semin Nucl Med 1997; 27:334-345.
35. Harvey J, Cohen MM. Technetium-99-labeled leukocytes in diagnosing diabetic osteomyelitis in the foot. J Foot Ankle Surg 1997; 36:209-214.
36. Craig JG, Amin MB, Wu K, Eyler WR, van Holsbeeck MT, Bouffard JA, Shirazi K. Osteomyelitis of the diabetic foot: MR imaging-pathologic correlation. Radiology 1997; 203:849-855.
37. Nijhof MW, Oyen WJ, van Kampen A, Claessens RA, van der Meer JW, Corstens FH. Evaluation of infections of the locomotor system with indium-111-labeled human IgG scintigraphy. J Nucl Med 1997; 38:1300-1305.
38. Hakki S, Harwood SJ, Morrissey MA, Camblin JG, Laven DL, Webster WB Jr. Comparative study of monoclonal antibody scan in diagnosing orthopaedic infection. Clin Orthop 1997; 335:275-285.
39. Balsells M, Viade J, Millan M, Garcia JR, Garcia-Pascual L, del Pozo C, Anglada J. Prevalence of osteomyelitis in non-healing diabetic foot ulcers: usefulness of radiologic and scintigraphic findings. Diabetes Res Clin Pract 1997; 38:123-127.
40. Di Gregorio F, Bray A, Pedicelli A, Settecasi C, Priolo F. Diagnostic imaging of the diabetic foot. Rays 1997; 22:550-561.
41. Palestro CJ, Mehta HH, Patel M, Freeman SJ, Harrington WN, Tomas MB, Marwin SE. Marrow versus infection in the Charcot joint: indium-111 leukocyte and technetium-99m sulfur colloid scintigraphy. J Nucl Med 1998; 39:346-350.
42. Croll SD, Nicholas GG, Osborne MA, Wasser TE, Jones S. Role of magnetic resonance imaging in the diagnosis of osteomyelitis in diabetic foot infections. J Vasc Surg 1996; 24:266-270.
43. Crerand S, Dolan M, Laing P, Bird M, Smith ML, Klenerman L. Diagnosis of osteomyelitis in neuropathic foot ulcers. J Bone Joint Surg Br 1996; 78:51-55.
44. Johnson JE, Kennedy EJ, Shereff MJ, Patel NC, Collier BD. Prospective study of bone, indium-111-labeled white blood cell, and gallium-67 scanning for the evaluation of osteomyelitis in the diabetic foot. Foot Ankle Int 1996; 17:10-16.
45. Newman LG. Imaging techniques in the diabetic foot. Clin Podiatr Med Surg 1995; 12:75-86.
46. Eckman MH, Greenfield S, Mackey WC, Wong JB, Kaplan S, Sullivan L, et al. Foot infections in diabetic patients. Decision and cost-effectiveness analyses. J Am Med Assoc 1995; 273:712-720.
47. Levine SE, Neagle CE, Esterhai JL, Wright DG, Dalinka MK. Magnetic resonance imaging for the diagnosis of osteomyelitis in the diabetic patient with a foot ulcer. Foot Ankle Int 1994; 15:151-156.
48. Scheidler J, Leinsinger G, Pfahler M, Kirsch CM. Diagnosis of osteomyelitis. Accuracy and limitations of antigranulocyte antibody imaging compared to three-phase bone scan. Clin Nucl Med 1994; 19:731-737.
49. Weinstein D, Wang A, Chambers R, Stewart CA, Motz HA. Evaluation of magnetic resonance imaging in the diagnosis of osteomyelitis in diabetic foot infections. Foot Ankle Int 1993; 14:18-22.
50. m-labelled anti-granulocyte antibodies. Nucl Med Commun 1993; 14:212-218.
51. Newman LG, Waller J, Palestro CJ, Hermann G, Klein MJ, Schwartz M, et al. Leukocyte scanning with 111In is superior to magnetic resonance imaging in diagnosis of clinically unsuspected osteomyelitis in diabetic foot ulcers. Diabetes Care 1992; 15:1527-1530.
52. Ritter MM, Richter WO, Leinsinger G, Kirsch CM, Schwandt P. Granulocytes and three-phase bone scintigraphy for differentiation of diabetic gangrene with and without osteomyelitis. Diabetes Care 1992; 15:1014-1019.
53. Oyen WJ, Netten PM, Lemmens JA, Claessens RA, Lutterman JA, van der Vliet JA, et al. Evaluation of infectious diabetic foot complications with indium-111-labeled human nonspecific immunoglobulin G. J Nucl Med 1992; 33:1330-1336.
54. Newman LG, Waller J, Palestro CJ, Schwartz M, Klein MJ, Hermann G, et al. Unsuspected osteomyelitis in diabetic foot ulcers. Diagnosis and monitoring by leukocyte scanning with indium in 111 oxyquinoline. J Am Med Assoc 1991; 266:1246-1251.
55. Wegener WA, Alavi A. Diagnostic imaging of musculoskeletal infection. Roentgenography; gallium, indium-labeled white blood cell, gammaglobulin, bone scintigraphy; and MRI. Orthop Clin North Am 1991; 22:401-418.
56. Larcos G, Brown ML, Sutton RT. Diagnosis of osteomyelitis of the foot in diabetic patients: value of 111In-leukocyte scintigraphy. Am J Roentgenol 1991; 157:527-531.
57. Wang A, Weinstein D, Greenfield L, Chiu L, Chambers R, Stewart C, et al. MRI and diabetic foot infections. Magn Reson Imaging 1990; 8:805-809.
58. Zeiger LS, Fox IM. Use of indium-111-labeled white blood cells in the diagnosis of diabetic foot infections. J Foot Surg 1990; 29:46-51.
59. Lipsky BA, Pecoraro RE, Wheat LJ. The diabetic foot. Soft tissue and bone infection. Infect Dis Clin North Am 1990; 4:409-432.
60. Gandsman EJ, Deutsch SD, Kahn CB, McCullough RW. Differentiation of Charcot joint from osteomyelitis through dynamic bone imaging. Nucl Med Commun 1990; 11:45-53.
61. Seabold JE, Flickinger FW, Kao SC, Gleason TJ, Kahn D, Nepola JV, Marsh JL. Indium-111-leukocyte/technetium-99m-MDP bone and magnetic resonance imaging: difficulty of diagnosing osteomyelitis in patients with neuropathic osteoarthropathy. J Nucl Med 1990; 31:549-556.
62. Yuh WT, Corson JD, Baraniewski HM, Rezai K, Shamma AR, Kathol MH, et al. Osteomyelitis of the foot in diabetic patients: evaluation with plain film, 99mTc-MDP bone scintigraphy, and MR imaging. Am J Roentgenol 1989; 152:795-800.
63. Keenan AM, Tindel NL, Alavi A. Diagnosis of pedal osteomyelitis in diabetic patients using current scintigraphic techniques. Arch Intern Med 1989; 149:2262-2266.
64. Segall GM, Nino-Murcia M, Jacobs T, Chang K. The role of bone scan and radiography in the diagnostic evaluation of suspected pedal osteomyelitis. Clin Nucl Med 1989; 14:255-260.
65. Schauwecker DS, Park HM, Burt RW, Mock BH, Wellman HN. Combined bone scintigraphy and indium-111 leukocyte scans in neuropathic foot disease. J Nucl Med 1988; 29:1651-1655.
66. Tawn DJ, O'Hare JP, O'Brien IA, Watt I, Dieppe PA, Corrall RJ. Bone scintigraphy and radiography in the early recognition of diabetic osteopathy. Br J Radiol 1988; 61:273-279.
67. Maurer AH, Millmond SH, Knight LC, Mesgarzadeh M, Siegel JA, Shuman CR, et al. Infection in diabetic osteoarthropathy: use of indium-labeled leukocytes for diagnosis. Radiology 1986; 161:221-225.
68. Seldin DW, Heiken JP, Feldman F, Alderson PO. Effect of soft-tissue pathology on detection of pedal osteomyelitis in diabetics. J Nucl Med 1985; 26:988-993.
69. Alazraki N, Dries D, Datz F, Lawrence P, Greenberg E, Taylor A Jr. Value of a 24-hour image (four-phase bone scan) in assessing osteomyelitis in patients with peripheral vascular disease. J Nucl Med 1985; 26:711-717.
70. Sartoris DJ, Devine S, Resnick D, Golbranson F, Fierer J, Witztum K, et al. Plantar compartmental infection in the diabetic foot. The role of computed tomography. Invest Radiol 1985; 20:772-784.
71. Edmonds ME, Clarke MB, Newton S, Barrett J, Watkins PJ. Increased uptake of bone radiopharmaceutical in diabetic neuropathy. Q J Med 1985; 57:843-855.
72. Visser HJ, Jacobs AM, Oloff L, Drago JJ. The use of differential scintigraphy in the clinical diagnosis of osseous and soft tissue changes affecting the diabetic foot. J Foot Surg 1984; 23:74-85.
73. Park HM, Wheat LJ, Siddiqui AR, Burt RW, Robb JA, Ransburg RC, Kernek CB. Scintigraphic evaluation of diabetic osteomyelitis: concise communication. J Nucl Med 1982; 23:569-573.
74. Knight D, Gray HW, McKillop JH, Bessent RG. Imaging for infection: caution required with the Charcot joint. Eur J Nucl Med 1988; 13:523-526.
75. Fox IM, Zeiger L. Tc-99m-HMPAO leukocytes scintigraphy for the diagnosis of osteomyelitis in diabetic foot infection. J Foot Ankle Surg 1993; 32:591-594.
76. 99mTc-HMPAO labeled leukocytes. J Foot Ankle Surg 1997; 36:120-126.
77. Devillers A, Moisan A, Hennion F, Garin E, Poirier JY, Bourguet P. Contribution of technetium-99m hexamethyl propylene amine oxime labeled leukocyte scintigraphy to the diagnosis of diabetic foot infection. Eur J Nucl Med 1998; 25:132-138.
78. Keenan AM, Tindel NL, Alavi A. Diagnosis of pedal osteomyelitis in diabetic patients using current scintigraphic techniques. Arch Intern Med 1989; 149:2262-2266.
79. Newman LG, Waller J, Palestro CJ, Schwartz M, Klein MJ, Hermann G, et al. Unsuspected osteomyelitis in diabetic foot ulcers: diagnosis and monitoring by leukocyte scanning with In-111 oxyquinoline. J Am Med Assoc 1991; 266:1246-1251.
80. Palestro CJ, Roumanas P, Swyer AJ, Kim CK, Goldsmith SJ. Diagnosis of musculoskeletal infection using combined In-111 labeled leukocyte and Tc-99m SC marrow imaging. Clin Nucl Med 1992; 17:269-273.
81. Tomas MB, Patel M, Marwin SE, Palestro CJ. The diabetic foot. Br J Radiol 2000; 73:443-450.
82. Unal SN, Birinci H, Baktiroglu S, Cantez S. Comparison of Tc-99m methylene diphosphonate, Tc-99m human immuno globulin, and Tc-99m-labeled white blood cell scintigraphy in the diabetic foot. Clin Nucl Med 2001; 26:1016-1021.
83. Oyen WJG, Netten PM, Lemmens AM, Claessens RA, Lutterman JA, van der Vliet JA, et al. Evaluation of infectious diabetic foot complication with In-111-labelled human nonspecific immunoglobulin G. J Nucl Med 1992; 33:1330-1336.